Researchers at University of São Paulo have identified a molecule in the venom of a species of Amazonian scorpion, Brotheas amazonicus, that acts against breast cancer cells similarly to chemotherapy drugs. Researchers discovered a bioactive molecule called BamazScplp1 in its venom that has potential anti-tumor properties. They are now dedicated to cloning and expressing bioactive molecules.